Home > Browse Research > Life Sciences > Biotechnology > Antibody Technologies

Antibody Technologies: market research reports

Antibody Technologies market research reports and industry analysis

Biologics Pipelines: Who Has the Next Promising Monoclonal Antibodies? 3/18/2008 \| published by: Decision Resources ... expert insight from our Decision Resources analysts, we look at approximately 70 MAbs in latestage development, identify promising MAbs, and discuss four developing trends in MAb markets. Get the Answers You Need to Shape Your ... \| read more...	$4,600.00
Global Immunochemicals Markets 1/21/2008 \| published by: Frost & Sullivan ... European, Japanese and Rest-of-World markets. The study takes into account immunochemicals, which include the following commercially produced antibodies for research purposes: polyclonal antibodies, monoclonal antibodies and conjugated antibodies. This research service is available through our ... \| read more...	$6,500.00
Monoclonal Therapeutics and Companion Diagnostic Products 1/1/2008 \| published by: BCC Research ... We were particularly interested in the position of the antibody market in the immediate future compared to how it has performed in the recent past as well as how the market compares to that of ... \| read more...	$5,450.00
The Avastin Juggernaut: Transformation of the Age-Related Macular Degeneration Market 12/19/2007 \| published by: Decision Resources ... is receiving signifi cant off-label use. The pending results of two head-to-head studies could strongly affect the AMD market, treatment schemes, reimbursement requirements, and clinical trial design. Get the Answers You Need to Shape Your ... \| read more...	$4,600.00
Next-Generation Biologics: Improving on Monoclonal Antibodies 12/12/2007 \| published by: Decision Resources ... production of MAbs have revealed that antibody fragments and other smaller, less complex proteins have the potential to overcome many disadvantages of MAbs, and researchers have begun to explore the therapeutic potential of peptides and ... \| read more...	$4,600.00
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market 5/1/2007 \| published by: Kalorama Information ... is going to dramatically change. as detailed in the report Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments: World Market from Kalorama Information. One of the most promising new approaches in modern cancer treatment is ... \| read more...	$995.00
China Antibodies 4/1/2007 \| published by: GBI ... increasing prestige of its scientific institutes have provided China with a strong platform for high-tech development. China Antibodies is an essential resource for companies, investors and entrepreneurs interested in accessing China’s antibody industry. This report ... \| read more...	$2,000.00
Immunotherapy of Cancer 3/30/2007 \| published by: BCC Research ... data for cancer treatment and therapies, the latest market trends, and 5-year forecasts and estimates through 2012; A section on industry structure with strategies employed by Big Pharma as well as top-selling drug patent expirations ... \| read more...	$5,450.00
Are Biologics the Wave of the Future? 3/30/2007 \| published by: Decision Resources ... wave that began 25 years ago while others were left behind. Big pharma, in particular, has taken a long time to recognize the vital importance of biologics in today's marketplace. Big pharma is now on ... \| read more...	$4,600.00
2007 Antibody Report: Current Trends and Future Outlook 3/19/2007 \| published by: Biocompare ... a discussion of the survey results and conclusions and recommendations drawn from both an analysis of the antibody market and the survey data. The market overview describes the use of antibodies in a wide array ... \| read more...	$3,500.00
Next Generation Protein Engineering and Drug Design 2/23/2007 \| published by: Business Insights ... in-depth analysis of patenting trends and market forecasts to 2011. rbdd0013 Features and benefits Gain access to the product pipelines of your key competitors. Exploit innovative protein engineering technology in your drug discovery process. Learn ... \| read more...	$2,875.00
Next Generation Protein Engineering and Drug Design: Strategies to boost efficacy and improve drug delivery 2/1/2007 \| published by: Business Insights ... will ensure a competitive edge in developing improved protein and peptide based therapeutics. Next Generation Protein Engineering and Drug Design provides a detailed insight into the current market for engineered proteins and peptides, and explores ... \| read more...	$2,875.00
Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight 1/11/2007 \| published by: Arrowhead Publishers ... Monoclonal antibody (MAbs) therapies have been posting the fastest growth within the protein therapeutics market. According to Arrowhead Publishers’ report Monoclonal Antibody Therapies 2007: Competitive Landscape and Pipeline Insight the value of this market is ... \| read more...	$2,250.00
Competitive Outlook on Apoptosis in Oncology 12/19/2006 \| published by: BioSeeker Group AB ... landscape assessment of the apoptopic market in oncology Thorough review of utilized targets in apoptopic drug development Thorough review of approved drugs Progress analysis of five major cancer indications, including players, drugs, clinical progress and ... \| read more...	$2,828.00
Complete Guide to Targeted Therapies in Oncology: A World Review 12/19/2006 \| published by: BioSeeker Group AB ... of more specifically targeting cancer cells. Research and analysis highlights In this comprehensive report covering targeted therapies in oncology, BioSeeker Group has analyzed apoptopic agents, protein kinase inhibitors, anti-angiogenic and vascular targeting agents, immunostimulators, antibodies ... \| read more...	$7,178.00
The Global Protein Therapeutics Market: Market Dynamics and Pipeline Analysis 12/7/2006 \| published by: Arrowhead Publishers ... Recombinant proteins are potentially advantageous in terms of higher efficacy and fewer side effects than other pharmaceutical products, as they can be more specifically targeted to the cause of the disease, rather than the treatment ... \| read more...	$3,250.00
Antibody Therapeutics: Product Development, Market Trends, and Strategic Issues (Revised Edition) 10/1/2006 \| published by: Drug and Market Development Publishing ... developments are primarily in the antibody market place and in clinical development areas as opposed to in the antibody discovery field as was observed in the early part of this decade. About the Author Rathin ... \| read more...	$4,950.00
Technology Developments in Functional Proteomics (Technical Insights) 9/30/2006 \| published by: Frost & Sullivan ... are impacting the field. In this study, Frost & Sullivan's expert analysts thoroughly examine the following applications: drug discovery, biomarkers, molecular diagnostics and antibody therapies, enabling technologies, spectometry, microarrays, electrophoresis, immunohistochemistry, yeast and viral expression ... \| read more...	$6,000.00
Proteomics: Current State and Future Directions 9/1/2006 \| published by: CHI Insight Pharma Reports ... Advances report that delivers an up-to-the-minute assessment of the state of proteomics and its applications in drug and biomarker discovery. The report provides insight into: Strengths and weaknesses of the leading technologies for protein separation, ... \| read more...	$2,500.00
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology 8/3/2006 \| published by: BioSeeker Group AB ... of innovative drug candidates. This extensive 380+ pages report compiles and analyzes in parallel the progress concerning drug development and competitive situation in the three mentioned key oncology areas. The report will not only provide ... \| read more...	$5,003.00
The Future of Monoclonal Antibodies Therapeutics: Innovation In Antibody Engineering, Key Growth Strategies And Forecasts To 2011 7/1/2006 \| published by: Business Insights ... antibody production in 1975, which allowed the production of the first mAb to market; Johnson & Johnson’s Orthoclone OKT3 (muromonab) in 1986. The mAb market is highly innovative and a key trend has been the ... \| read more...	$2,875.00
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies 6/29/2006 \| published by: BioSeeker Group AB ... oncology. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as ... \| read more...	$4,092.00
Chronic Lymphocytic Leukemia: Monoclonal Antibodies Will Drive Steady Growth 6/14/2006 \| published by: Decision Resources ... biological agents with established chemotherapy, as well as increased drug therapy for early-stage patients who are likely to progress based on potential prognostic markers, have already begun and will continue to create market opportunities and ... \| read more...	$4,600.00
The Protein Therapeutics Market: The Science and Business of a Growing Sector 6/1/2006 \| published by: Kalorama Information ... including market size and growth, competitive market share, geographical segmentation, top products, and forecasts to 2010 for each of the following individual product areas: Monoclonal Antibodies Erythropoietins Insulin Interferons Growth Factors Interleukins Blood Clotting Factors ... \| read more... Buy by the section \|	$995.00
The Market for Antibodies: Keys to Success for Commercial Suppliers, Volume II 6/1/2006 \| published by: BioInformatics, LLC ... 1,000 life scientists worldwide about the types of catalog antibodies that they use and their opinions of commercial suppliers. Building upon the best-selling 2004 market research report, The Market for Antibodies: Keys to Success for ... \| read more...	$500.00

< prev 1 2 3 4 5 6 7 8 9 10 next >